Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
K.S. Roth, B.H. Amaker, J.C.M. Chan.
Nephrotic syndrome: pathogenesis and management.
Pediatr Rev, 23 (2002), pp. 237-248
[2.]
A.E. Allison, J.M. Symons.
Nephrotic syndrome in childhood.
Lancet, 362 (2003), pp. 629-639
[3.]
J.M. Ginsberg, B.S. Chang, R.A. Matarese, S. Garella.
Use of single voided urine samples to estimate quantitative proteinuria.
N Engl J Med, 309 (1983), pp. 1543-1546
[4.]
P. Niaudet.
Steroid-sensitive idiopathic nephrotic syndrome in children.
Pediatric nephrology, pp. 543-556
[5.]
J.P. Guignard, F. Santos.
Laboratory investigations.
Pediatric nephrology, pp. 399-424
[6.]
S.R. Orth, E. Ritz.
The nephrotic syndrome.
N Engl J Med, 338 (1998), pp. 1202-1211
[7.]
S. Barbaux, P. Niaudet, M.C. Gubler, J.P. Grunfeld, F. Jaubert, F. Kuttenn, et al.
Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
Nat Genet, 17 (1997), pp. 467-470
[8.]
M. Kestila, U. Lenkkeri, M. Mannikko, J. Lamerdin, P. McCready, H. Putaala, et al.
Positionally cloned gene for a novel glomerular protein –nephrin– is mutated in congenital nephrotic syndrome.
Mol Cell, 1 (1998), pp. 575-582
[9.]
N. Boute, O. Gribouval, S. Roselli, F. Benessy, H. Lee, A. Fuchshuber, et al.
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.
Nat Genet, 24 (2000), pp. 349-354
[10.]
J.M. Kaplan, S.H. Kim, K.N. North, H. Rennke, L.A. Correia, H.Q. Tong, et al.
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.
Nat Genet, 24 (2000), pp. 251-256
[11.]
R. Salomon, M.C. Gubler, P. Niaudet.
Genetics of the nephrotic syndrome.
Curr Opin Pediatr, 12 (2000), pp. 129-134
[12.]
S.M. Karle, B. Uetz, V. Ronner, L. Glaeser, F. Hildebrandt, A. Fuchshuber, et al.
Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome.
J Am Soc Nephrol, 13 (2002), pp. 388-393
[13.]
V.E. Torres, S.J. Scheinman.
Genetic diseases of the kidney.
NephSAP, 3 (2004), pp. 5-70
[14.]
A.V. Moorthy, S.W. Zimmerman, P.M. Burkholder.
Inhibition of lymphocyte blastogenesis by plasma of patients with minimal- change nephrotic syndrome.
Lancet, 1 (1976), pp. 1160-1162
[15.]
K. Kobayashi, N. Yoshikawa, H. Nakamura.
T-cell subpopulations in childhood nephrotic syndrome.
Clin Nephrol, 41 (1994), pp. 253-258
[16.]
H.G. Herrod, F.B. Stapleton, R.L. Trouy, S. Roy.
Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome.
Clin Exp Immunol, 52 (1983), pp. 581-585
[17.]
B.J. Carrie, W.R. Salyer, B.D. Myers.
Minimal change nephropathy: an electrochemical disorder of the glomerular membrane.
Am J Med, 70 (1981), pp. 262-268
[18.]
A. Guasch, W.M. Deen, B.D. Myers.
Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
J Clin Invest, 92 (1993), pp. 2274-2282
[19.]
B. Birmele, G. Thibault, H. Nivet, A. De Agostini, E.P. Girardin.
In vitro decrease of glomerular heparan sulfate by lymphocytes from idiopathic nephrotic syndrome patients.
Kidney Int, 59 (2001), pp. 913-922
[20.]
G. Deschenes, E. Feraille, A. Doucet.
Mechanisms of oedema in nephrotic syndrome: old theories and new ideas.
Nephrol Dial Transplant, 183 (2003), pp. 454-456
[21.]
J. Klisic, J. Zhang, V. Nief, L. Reyes, O.W. Moe, P.M. Ambuhl.
Albumin regulates the Na+/H+ exchanger 3 in OKP cells.
J Am Soc Nephrol, 14 (2003), pp. 3008-3016
[22.]
U. Querfeld.
Should hyperlipidemia in children with the nephrotic sindrome be treated?.
Pediatr Nephrol, 13 (1999), pp. 77-84
[23.]
L. Callis Bracons.
Sindrome nefrotico idiopatico.
Nefrologia pediatrica, pp. 141-151
[24.]
M. Broyer, F. Terzi, A. Lehnert, M.F. Gagnadoux, G. Guest, P. Niaudet.
A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.
Pediatr Nephrol, 11 (1997), pp. 418-422
[25.]
G. Filler.
Treatment of nephrotic syndrome in children and controlled trials.
Nephrol Dial Transplant, 18 (2003), pp. 75-78
[26.]
M. Hiraoka, H. Tsukahara, K. Matsubara, M. Tsurusawa, N. Takeda, S. Haruki, et al.
A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
Am J Kidney Dis, 41 (2003), pp. 1155-1162
[27.]
E.M. Hodson, J.F. Knight, N.S. Willis, J.C. Craig.
Corticosteroid therapy for nephrotic syndrome in childen (Cochrane review).
Cochrane Database Syst Rev, 1 (2003), pp. CD001533
[28.]
R.J. Hogg, R.J. Potman, D. Milliner, K.V. Lemley, A. Eddy, J. Ingelfinger.
Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE).
Pediatrics, 105 (2000), pp. 1242-1249
[29.]
K. Latta, C. Von Schnakenburg, J.H.H. Ehrich.
A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children.
Pediatr Nephrol, 16 (2001), pp. 271-282
[30.]
F. Fakhouri, N. Bocquet, P. Taupin, C. Presne, M.F. Gagnadoux, P. Landais, et al.
Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
Am J Kidney Dis, 41 (2003), pp. 550-557
[31.]
M. Camoins Marti, J. Casal Lombos, D. Tarrago Asensio, M.J. Rodrigo Anoro, A. Allepuz Palau, L. Callis Bracons.
Persistencia de anticuerpos a los 3 anos de la inmunizacion antineumococica 23-valente en pacientes con sindrome nefrotico.
An Pediatr (Barc), 58 (2003), pp. 184-187
[32.]
B. Amil, F. Santos, F.A. Ordonez, V. Martinez, S. Malaga.
Severe acute abdominal pain in a patient with steroid-sensitive idiopathic nephrotic syndrome.
Pediatr Nephrol, 17 (2002), pp. 875-876
[33.]
British Association for Paediatric Nephrology.
Levamisole for corticosteroid-dependent nephrotic syndrome in childhood.
Lancet, 337 (1991), pp. 1555-1557
[34.]
A.M. Durkan, E.M. Hodson, N.S. Willis, J.C. Craig.
Immunosuppressive agents in childhood nephrotic syndrome: a metaanalysis of randomized controlled trials.
Kidney Int, 59 (2001), pp. 1919-1927
[35.]
M.J. Choi, J.A. Eustace, L.F. Gimenez, M.G. Atta, P.J. Scheel, R. Sothinathan, et al.
Mycophenolate mofetil treatment for primary glomerular diseases.
Kidney Int, 61 (2002), pp. 1098-1114
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados